138. Nerve cell migration disorder Disease details / Clinical trials / Drug dev / DR info /


Clinical trials : 2 Drugs : 3 - (DrugBank : 2) / Drug target gene : 1 - Drug target pathways : 103

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Alpelisib
   Centre Hospitalier Universitaire Dijon
      2022   Phase 2   NCT05577754   France
Optional lumbar puncture + blood sample
   Centre Hospitalier Universitaire Dijon
      2022   Phase 2   NCT05577754   France
RLY-2608
   Relay Therapeutics, Inc.
      2025   Phase 2   NCT06789913   United States